Lantheus Holdings (LNTH) Reiterated at Market Outperform by Citizens on FDA CRL
Tweet Send to a Friend
Citizens analyst David Turkaly reiterated a Market Outperform rating and $115.00 price target on Lantheus Holdings (NASDAQ: LNTH).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
